Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Kaye

Showing results (211-220 of 411) with videos related to

Pageof 42
Sort By:
The British Journal of Ophthalmology|February 1, 1990
Ocular shedding of herpes simplex virusS B Kaye, N Madan, T C Dowd, et al.
British Journal of Cancer|February 1, 1993
Oral piritrexim, an effective treatment for metastatic urothelial cancerR de Wit, S B Kaye, J T Roberts, et al.
British Journal of Cancer|June 1, 1988
Phase II study of the thymidylate synthetase inhibitor CB3717 (N10-propargyl-5,8-dideazafolic acid) in colorectal cancerM J Harding, B M Cantwell, R A Milstead, et al.
Biochemical Pharmacology|March 15, 1989
Activity of N-(2-hydroxypropyl)methacrylamide copolymers containing daunomycin against a rat tumour modelJ Cassidy, R Duncan, G J Morrison, et al.
The British Journal of Ophthalmology|July 1, 1992
Non-traumatic acquisition of herpes simplex virus infection through the eyeS B Kaye, C Shimeld, E Grinfeld, et al.
Cancer Chemotherapy and Pharmacology|January 27, 1998
Clinical trials of nimodipine as a potential neuroprotector in ovarian cancer patients treated with cisplatinJ Cassidy, J Paul, M Soukop, et al.
Developmental Medicine and Child Neurology|June 4, 2004
Congenital ocular motor apraxia associated with idiopathic generalized epilepsy in monozygotic twinsJ A Gonzalez-Martin, L C Kaye, M Brown, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2008
Does body mass index affect progression-free or overall survival in patients with ovarian cancer? Results from SCOTROC I trialS V Barrett, J Paul, A Hay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Reduced MLH1 expression in breast tumors after primary chemotherapy predicts disease-free survivalH J Mackay, D Cameron, M Rahilly, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1983
On the receiving end--patient perception of the side-effects of cancer chemotherapyA Coates, S Abraham, S B Kaye, et al.
Pageof 42

Showing results (211-220 of 411) with videos related to

Sort By:
Pageof 42
The British Journal of Ophthalmology|February 1, 1990
Ocular shedding of herpes simplex virusS B Kaye, N Madan, T C Dowd, et al.
British Journal of Cancer|February 1, 1993
Oral piritrexim, an effective treatment for metastatic urothelial cancerR de Wit, S B Kaye, J T Roberts, et al.
British Journal of Cancer|June 1, 1988
Phase II study of the thymidylate synthetase inhibitor CB3717 (N10-propargyl-5,8-dideazafolic acid) in colorectal cancerM J Harding, B M Cantwell, R A Milstead, et al.
Biochemical Pharmacology|March 15, 1989
Activity of N-(2-hydroxypropyl)methacrylamide copolymers containing daunomycin against a rat tumour modelJ Cassidy, R Duncan, G J Morrison, et al.
The British Journal of Ophthalmology|July 1, 1992
Non-traumatic acquisition of herpes simplex virus infection through the eyeS B Kaye, C Shimeld, E Grinfeld, et al.
Cancer Chemotherapy and Pharmacology|January 27, 1998
Clinical trials of nimodipine as a potential neuroprotector in ovarian cancer patients treated with cisplatinJ Cassidy, J Paul, M Soukop, et al.
Developmental Medicine and Child Neurology|June 4, 2004
Congenital ocular motor apraxia associated with idiopathic generalized epilepsy in monozygotic twinsJ A Gonzalez-Martin, L C Kaye, M Brown, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2008
Does body mass index affect progression-free or overall survival in patients with ovarian cancer? Results from SCOTROC I trialS V Barrett, J Paul, A Hay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Reduced MLH1 expression in breast tumors after primary chemotherapy predicts disease-free survivalH J Mackay, D Cameron, M Rahilly, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1983
On the receiving end--patient perception of the side-effects of cancer chemotherapyA Coates, S Abraham, S B Kaye, et al.
Pageof 42